BioSpace News Archive

Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced changes in the leadership of its Board of Directors

CONMED Corporation announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on April 5, 2021 to all shareholders of record as of March 15, 2021.

Intersect ENT, Inc., a global ear, nose and throat medical technology leader dedicated to transforming patient care, announced that it will release fourth quarter and full year 2020 financial results on Tuesday, March 9, 2021.

Ambrx, a clinical stage biopharmaceutical company using an expanded genetic code to create Engineered Precision Biologics, today announced the appointment of Chris Nolet to the company’s Board of Directors.

Arena Pharmaceuticals, Inc. provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2020.

Masimo (Nasdaq: MASI) today announced its financial results for the fourth quarter and full-year ended January 2, 2021.

bluebird bio, Inc. reported financial results and business highlights for the fourth quarter and full year ended December 31, 2020 and shared recent operational progress.

PPD, Inc., a leading global contract research organization, reported its financial results for the fourth quarter and full year ended December 31, 2020.

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases, announced that management will be presenting at the Cowen 41st Annual Health Care Conference on Thursday, March 4 at 9:50 a.m. ET.

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the Company will participate in the “Novel Oncology Targets” panel discussion at the Cowen 41st Annual Health Care Conference